THIS COMPONENT IS ENTITLED THE CENTER FOR BIOMEDICAL INFORMATICS ABSTRACT Project Summary Statement The field of biomedical informatics ? the application of computer science, information technology and analytics to the problems in healthcare and biomedical research data ? is a critical and necessary component of effective translational cancer research. The physician-scientist must have access to complex datasets: i) that exist within and across institutions, and ii) are integrated or can be integrated from varying sources (e.g. tumor registries, clinical studies, medical records). The Center for Biomedical Informatics (CBMI) supplies the development, deployment, and support of enterprise-wide informatics infrastructure facilitating cancer clinical and translational research broadly across multiple functions including: clinical studies data management; biospecimen data management; tumor registry and medical record data mining; and, support of in silico analyses of microarray and NextGen sequencing data sets. Hence, the CBMI will support key data management, integration, mining, and analytical challenges to propel research within the Siteman Cancer Center (SCC). Realizing the need for informatics in scientific progression, the SCC established the Biomedical Informatics Core in 2002. The core was expanded in 2007 when the Washington University Clinical and Translational Science Award (CTSA) built on the SCC core to establish the Center for Biomedical Informatics (CBMI). These activities resulted in the coalescence of informatics at Washington University (WU) into the CBMI through the consolidation of personnel, hardware and software through the SCC, CTSA and P30-based cores allowing for this expansion of resources while meeting the needs of SCC constituents.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA091842-17
Application #
9514028
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
17
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Stephens, Calvin J; Kashentseva, Elena; Everett, William et al. (2018) Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9. Gene Ther 25:139-156
Trissal, Maria C; Wong, Terrence N; Yao, Juo-Chin et al. (2018) MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis. Cancer Res 78:3510-3521
Copper, Tara Conway; Jeffe, Donna B; Ahmad, Fahd A et al. (2018) Emergency Information Forms for Children With Medical Complexity: A Qualitative Study. Pediatr Emerg Care :
McGill, Bryan E; Barve, Ruteja A; Maloney, Susan E et al. (2018) Abnormal Microglia and Enhanced Inflammation-Related Gene Transcription in Mice with Conditional Deletion of Ctcf in Camk2a-Cre-Expressing Neurons. J Neurosci 38:200-219
Sharma, Piyush K; Dmitriev, Igor P; Kashentseva, Elena A et al. (2018) Development of an adenovirus vector vaccine platform for targeting dendritic cells. Cancer Gene Ther 25:27-38
Liu, Ying; Colditz, Graham A; Rosner, Bernard A et al. (2018) Comparison of Performance Between a Short Categorized Lifestyle Exposure-based Colon Cancer Risk Prediction Tool and a Model Using Continuous Measures. Cancer Prev Res (Phila) 11:841-848
Dodson, Elizabeth A; Hipp, J Aaron; Lee, Jung Ae et al. (2018) Does Availability of Worksite Supports for Physical Activity Differ by Industry and Occupation? Am J Health Promot 32:517-526
Bauerle, Kevin T; Hutson, Irina; Scheller, Erica L et al. (2018) Glucocorticoid Receptor Signaling Is Not Required for In Vivo Adipogenesis. Endocrinology 159:2050-2061
Garbow, Joel R; Tsien, Christina I; Beeman, Scott C (2018) Preclinical MRI: Studies of the irradiated brain. J Magn Reson 292:73-81
Chiu, Ami; Hartz, Sarah; Smock, Nina et al. (2018) Most Current Smokers Desire Genetic Susceptibility Testing and Genetically-Efficacious Medication. J Neuroimmune Pharmacol 13:430-437

Showing the most recent 10 out of 1244 publications